Cetera Trust Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2K Hold
75
0.01% 270
2026
Q1
$13.8K Hold
75
0.01% 273
2025
Q4
$13.2K Hold
75
0.01% 271
2025
Q3
$10.5K Hold
75
0.01% 293
2025
Q2
$9.42K Hold
75
0.01% 297
2025
Q1
$10.3K Hold
75
0.01% 289
2024
Q4
$11.5K Hold
75
0.01% 280
2024
Q3
$14.5K Hold
75
0.01% 273
2024
Q2
$17.4K Hold
75
0.01% 264
2024
Q1
$16.2K Hold
75
0.01% 269
2023
Q4
$19.4K Buy
+75
New +$18.4K 0.01% 258

Other funds holding BIIB

Cetera Trust Company's BIIB Position: Q2 2026 in Review

Cetera Trust Company held its Biogen (BIIB) position steady in Q2 2026 at 75 shares worth $16.2K. The position accounts for 0.01% of the portfolio, ranked #270.

Cetera Trust Company first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.4K in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Cetera Trust Company held 75 shares of Biogen worth $16.2K as of Q2 2026.
  • Cetera Trust Company left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Cetera Trust Company's portfolio in Q2 2026, its #270 holding.
  • Cetera Trust Company first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's Biogen position peaked at $19.4K in Q4 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.